Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1963 Oct 31;118(5):681–698. doi: 10.1084/jem.118.5.681

COMPLEMENT AS A MEDIATOR OF INFLAMMATION

ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE

Oscar D Ratnoff 1, Irwin H Lepow 1
PMCID: PMC2137679  PMID: 14087615

Abstract

Purified preparations of the esterase derived from the first component of complement (C'1 esterase) increased vascular permeability in guinea pig skin, an effect inhibited by triprolidine, an antihistaminic agent, but not by soy bean trypsin inhibitor. The permeability-increasing and esterolytic properties of C'1 esterase were inhibited in parallel by the serum inhibitor of C'1 esterase, diisopropylphosphofluoridate and extremes of temperature and pH. Moreover, the permeability-increasing and esterolytic properties evolved in parallel when C'1 esterase was generated from its subcomponents. How C'1 esterase induces changes in vascular permeability remains unexplained, although the possibility that its action is mediated through a histamine-like agent is attractive.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUSTEN K. F., BROCKLEHURST W. E. Anaphylaxis in chopped guinea pig lung. I. Effect of peptidase substrates and inhibitors. J Exp Med. 1961 Mar 1;113:521–539. doi: 10.1084/jem.113.3.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BECKER E. L. Concerning the mechanism of complement action. II. The nature of the first component of guinea pig complement. J Immunol. 1956 Dec;77(6):469–478. [PubMed] [Google Scholar]
  3. BECKER E. L. Concerning the mechanism of complement action. V. The early steps in immune hemolysis. J Immunol. 1960 Mar;84:299–308. [PubMed] [Google Scholar]
  4. BHOOLA K. D., CALLE J. D., SCHACHTER M. The effect of bradykinin, serum kallikrein and other endogenous substances on capillary permeability inthe guinea-pig. J Physiol. 1960 Jun;152:75–86. doi: 10.1113/jphysiol.1960.sp006470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BIER O. G., SIQUEIRA M., OSLER A. G. Studies on the mechanism of hypersensitivity phenomena. I. The effect of in vivo antigen-antibody reactions on passive cutaneous anaphylaxis in the rat. Int Arch Allergy Appl Immunol. 1955;7(1):1–9. doi: 10.1159/000228200. [DOI] [PubMed] [Google Scholar]
  6. BLOCH K. J., KOURILSKY F. M., OVARY Z., BENACERRAF B. Properties of guinea pig 7S antibodies. III. Identification of antibodies involved in complement fixation and hemolysis. J Exp Med. 1963 Jun 1;117:965–981. doi: 10.1084/jem.117.6.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BOAKE W. C., LOVELL R. R. The necrotizing activity of human sera for guinea-pig skin. Br J Exp Pathol. 1954 Aug;35(4):350–357. [PMC free article] [PubMed] [Google Scholar]
  8. BROCKLEHURST W. E., HUMPHREY J. H., PERRY W. L. The role of histamine in cutaneous antigen-antibody reactions in the rat. J Physiol. 1955 Aug 29;129(2):205–224. doi: 10.1113/jphysiol.1955.sp005348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DAVIES G. E., LOWE J. S. A permeability factor released from guinea-pig serum by antigen-antibody precipitates. Br J Exp Pathol. 1960 Aug;41:335–344. [PMC free article] [PubMed] [Google Scholar]
  10. DONALDSON V. H., EVANS R. R. A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. Am J Med. 1963 Jul;35:37–44. doi: 10.1016/0002-9343(63)90162-1. [DOI] [PubMed] [Google Scholar]
  11. DULBECCO R., VOGT M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954 Feb;99(2):167–182. doi: 10.1084/jem.99.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. ELDER J. M., WILHELM D. L. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. V. Activable permeability factor in human serum. Br J Exp Pathol. 1958 Aug;39(4):335–342. [PMC free article] [PubMed] [Google Scholar]
  13. ELLIOTT D. F., HORTON E. W., LEWIS G. P. Actions of pure bradykinin. J Physiol. 1960 Oct;153:473–480. doi: 10.1113/jphysiol.1960.sp006548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. GREISMAN S. E. Significance of vascular injurious factors in human plasma as determined by animal assay. II. Role of human complement in increasing capillary permeability. J Lab Clin Med. 1961 Mar;57:377–387. [PubMed] [Google Scholar]
  15. HOLDSTOCK D. J., MATHIAS A. P., SCHACHTER M. A comparative study of kinin, kallidin, and bradykinin. Br J Pharmacol Chemother. 1957 Jun;12(2):149–158. doi: 10.1111/j.1476-5381.1957.tb00113.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. HUMPHREY J. H., AUSTEN K. F., RAPP H. J. In vitro studies of reversed anaphylaxis with rat cells. Immunology. 1963 May;6:226–245. [PMC free article] [PubMed] [Google Scholar]
  17. Hinz C. F., Picken M. E., Lepow I. H. STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM OF ACTION OF COMPLEMENT AND THE ROLE OF C'1 AND C'1 ESTERASE. J Exp Med. 1961 Jan 1;113(1):193–218. doi: 10.1084/jem.113.1.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LEPOW I. H., LEON M. A. Interaction of a serum inhibitor of C'I-esterase with intermediate complexes of the immune haemolytic system. I. Specificity of inhibition of C'I activity associated with intermediate complexes. Immunology. 1962 Mar;5:222–234. [PMC free article] [PubMed] [Google Scholar]
  19. LEPOW I. H., NAFF G. B., TODD E. W., PENSKY J., HINZ C. F. Chromatographic resolution of the first component of human complement into three activities. J Exp Med. 1963 Jun 1;117:983–1008. doi: 10.1084/jem.117.6.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. LEPOW I. H., RATNOFF O. D., LEVY L. R. Studies on the activation of a proesterase associated with partially purified first component of human complement. J Exp Med. 1958 Mar 1;107(3):451–474. doi: 10.1084/jem.107.3.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. LEPOW I. H., RATNOFF O. D., PILLEMER L. Elution of an esterase from antigen-antibody aggregates treated with human complement. Proc Soc Exp Biol Med. 1956 May;92(1):111–114. doi: 10.3181/00379727-92-22401. [DOI] [PubMed] [Google Scholar]
  22. LEPOW I. H., RATNOFF O. D., ROSEN F. S., PILLEMER L. Observations on a pro-esterase associated with partially purified first component of human complement (C'1). Proc Soc Exp Biol Med. 1956 May;92(1):32–37. doi: 10.3181/00379727-92-22376. [DOI] [PubMed] [Google Scholar]
  23. LEPOW I. H., ROSS A. Studies on immune cellular injury. II. Functional role of C'1 esterase in immune cytotoxicity. J Exp Med. 1960 Dec 1;112:1107–1120. doi: 10.1084/jem.112.6.1107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. LEVINE L. Inhibition of immune hemolysis by diisopropyl fluorophosphate. Biochim Biophys Acta. 1955 Oct;18(2):283–284. doi: 10.1016/0006-3002(55)90069-x. [DOI] [PubMed] [Google Scholar]
  25. LEVY L. R., LEPOW I. H. Assay and properties of serum inhibitor of C'l-esterase. Proc Soc Exp Biol Med. 1959 Aug-Sep;101:608–611. doi: 10.3181/00379727-101-25034. [DOI] [PubMed] [Google Scholar]
  26. MAJNO G., PALADE G. E., SCHOEFL G. I. Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: a topographic study. J Biophys Biochem Cytol. 1961 Dec;11:607–626. doi: 10.1083/jcb.11.3.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. MARGOLIS J. Hagerman factor and capillary permeability. Aust J Exp Biol Med Sci. 1959 Jun;37:239–244. doi: 10.1038/icb.1959.24. [DOI] [PubMed] [Google Scholar]
  28. MULLER-EBERHARD H. J., KUNKEL H. G. Isolation of a thermolabile serum protein which precipitates gamma-globulin aggregates and participates in immune hemolysis. Proc Soc Exp Biol Med. 1961 Feb;106:291–295. doi: 10.3181/00379727-106-26313. [DOI] [PubMed] [Google Scholar]
  29. Menkin V. STUDIES ON INFLAMMATION : XIV. ISOLATION OF THE FACTOR CONCERNED WITH INCREASED CAPILLARY PERMEABILITY IN INJURY. J Exp Med. 1938 Jan 1;67(1):129–144. doi: 10.1084/jem.67.1.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. OSLER A. G., HAWRISIAK M. M., OVARY Z., SIQUEIRA M., BIER O. G. Studies on the mechanism of hypersensitivity phenomena. II. The participation of complement in passive cutaneous anaphylaxis of the albino rat. J Exp Med. 1957 Dec 1;106(6):811–834. doi: 10.1084/jem.106.6.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. OVARY Z. [Cutaneous anaphylaxis in the albino rat]. Int Arch Allergy Appl Immunol. 1952;3(4):293–301. doi: 10.1159/000227977. [DOI] [PubMed] [Google Scholar]
  32. PENSKY J., LEVY L. R., LEPOW I. H. Partial purification of a serum inhibitor of C'1-esterase. J Biol Chem. 1961 Jun;236:1674–1679. [PubMed] [Google Scholar]
  33. RATNOFF O. D., DAVIE E. W. The purification of activated Hageman factor (activated factor XII). Biochemistry. 1962 Nov;1:967–975. doi: 10.1021/bi00912a005. [DOI] [PubMed] [Google Scholar]
  34. RATNOFF O. D., LEPOW I. H. Some properties of an esterase derived from preparations of the first component of complement. J Exp Med. 1957 Aug 1;106(2):327–343. doi: 10.1084/jem.106.2.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. ROCHA E SILVA M., ROTHSCHILD A. M. Anaphylatoxin, histamine depletion and skin reactions in the rat. Nature. 1955 Jun 4;175(4466):987–988. doi: 10.1038/175987b0. [DOI] [PubMed] [Google Scholar]
  36. SPECTOR W. G. The role of some higher peptides in inflammation. J Pathol Bacteriol. 1951 Jan;63(1):93–110. doi: 10.1002/path.1700630111. [DOI] [PubMed] [Google Scholar]
  37. TARANTA A., WEISS H. S., FRANKLIN E. C. Precipitating factor for aggregated gamma-globulins in normal human sera. Nature. 1961 Jan 21;189:239–240. doi: 10.1038/189239a0. [DOI] [PubMed] [Google Scholar]
  38. WEBSTER M. E., PIERCE J. V. The nature of the kallidins released from human plasma by kallikreins and other enzymes. Ann N Y Acad Sci. 1963 Feb 4;104:91–107. doi: 10.1111/j.1749-6632.1963.tb17655.x. [DOI] [PubMed] [Google Scholar]
  39. WERLE E., FORELL M. M., MAIER L. Zur Kenntnis der blutdrucksenkenden Wirkung des Trypsins. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1955;225(5):369–380. [PubMed] [Google Scholar]
  40. WILHELM D. L., MILES A. A., MACKAY M. E. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. II. Isolation and properties of the permeability factor and its inhibitor. Br J Exp Pathol. 1955 Feb;36(1):82–104. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES